Background In the general population, prostate adenocarcinoma affects predominately older
men. If fact, most current guidelines suggest that males over the age of 50 years should …

Background Recent observations suggest that prostate cancer is an increasing disease
among older adolescents and young adults. Methods Incidence, mortality, and survival data …

OBJECTIVE: To compare clinicopathologic features and survival outcomes for men 50 years
of age in relation to other age groups stratified by race to further define prostate cancer …

BACKGROUND: Outcomes of treatment for young men compared with older men with
prostate cancer are poorly defined outside of limited institutional series. In this study, the …

Background: The incidence of prostate cancer increases with age and latent cancer is
common in older men. But clinical prostate cancer is rare in men aged< 50 years. Methods …

Background To examine clinical characteristics, treatment modalities and oncological
outcomes of prostate cancer (PCa) according to young (≤ 50) vs. old age. Methods Of …

Background. Prostate adenocarcinoma is predominantly a disease of older men. Males
younger than 50 years account for 1% of all patients with prostate cancer. The authors …

Objective: Prostate adenocarcinoma is predominantly a disease of elderly men. This study
retrospectively examined prostate adenocarcinoma in Japanese patients 80 years of age or …

Purpose: Currently there is a lack of consensus on screening recommendations for prostate
cancer with minimal guidance on the cessation of screening in older men. We defined the …

Background Early-onset prostate cancer patients (aged≤ 55 years) from Western countries
have been well characterized in previous studies. However, the clinicopathological and …